• TBD at CPHI Barcelona 2023

    TBD at CPHI Barcelona 2023

    ūüĆü TBD Pharmatech is excited to attend this year’s¬†CPHI¬†Barcelona 2023 on 24-26 Oct 2023. CPHI Barcelona brings together the key experts, innovators, and suppliers to showcase their state-of-the-art work.TBD Pharmatech is proud to be a part of this year’s group to showcase our EU-based API¬†CDMO¬†and GMP manufacturing services. Our 7 person delegation, including CEO¬†Andrus Tasa, is eager to connect with peers and future partners, as well as explore all opportunities.Reach out and we’ll meet you at STAND 7B30, API zone.

    Read more
  • Project: PharmaBoost – EstLat Alliance in Drug Development

    Drug substance development for smoking cessation On September 1st, 2023, TBD Pharmatech started together with the Latvian Institute of Organic Synthesis a new project PharmaBoost – EstLat Alliance in Drug Development. The total project funding amounts 582.436,25 EUR, with a substantial 80% contribution coming from the Estonia-Latvia Programme 2021-2027. This partnership embarks on a journey dedicated to advancing pharmaceutical development within the Baltic States. The primary goal is to pioneer an economically and environmentally sustainable production technology of an active pharmaceutical ingredient (API) crucial for a vital smoking cessation medication. Furthermore, the project is promoting the pharmaceutical innovation in the

    Read more